XML 24 R7.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Cash Flows from Operating Activities:    
Net Income (Loss) $ 340,437 $ 86,759
Adjustments to reconcile net income to net cash provided by operation activities -    
Depreciation, depletion, and amortization 133,982 68,629
Accretion of asset retirement obligation 534 306
Deferred income taxes 9,625 6,212
Stock-based compensation expense 5,086 4,645
Gain (Loss) on Sale of Derivatives 73,885 123,018
Cash Received (Paid) On Settlements of Derivative Contracts (219,626) (70,582)
Asset Retirement Obligation, Cash Paid to Settle (48) (158)
Write off of Deferred Debt Issuance Cost 350 229
Other Noncash Income (Expense) 3,010 2,877
Change in assets and liabilities-    
(Increase) decrease in accounts receivable and other assets (29,522) (23,513)
Increase (decrease) in accounts payable and accrued liabilities 11,788 17,507
Increase (decrease) in income taxes payable 229 (83)
Increase (decrease) in accrued interest 1,969 (286)
Net Cash Provided by Operating Activities 331,241 215,726
Cash Flows from Investing Activities:    
Additions to property and equipment (272,443) (133,638)
Acquisition of properties (367,024) (51,734)
Proceeds from Sale of Property, Plant, and Equipment (4,347) 0
Payments for (Proceeds from) Other Investing Activities (750) (1,084)
Net Cash Used in Investing Activities (635,870) (186,456)
Cash Flows from Financing Activities:    
Payments of long-term debt 0 (50,000)
Proceeds from bank borrowings 841,000 335,000
Payments of bank borrowings (526,000) (338,000)
Proceeds from Issuance or Sale of Equity 0 26,956
Proceeds from Stock Options Exercised 39 0
Purchase of treasury shares (3,397) (612)
Payments of debt issuance costs (7,342) (3,611)
Net Cash Provided by (Used in) Financing Activities 304,300 (30,267)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect (329) (997)
Total Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 792 1,121
Supplemental Disclosures of Cash Flows Information:    
Cash paid during period for interest, net of amounts capitalized 36,994 27,221
Increase (decrease) in accrued payables for capital 54,372 (4,033)
Other Significant Noncash Transaction, Value of Consideration Given $ (156,252) $ (83,522)